News & Analysis on Contract Research, Manufacturing & Clinical Trials
DCAT WEEK '17
Lubrizol LifeSciences: Looking at long term partnerships
By Melissa Fassbender
- Last updated on
Mark Mitchnick, MD, CEO at Particle Sciences, CMO at Lubrizol LifeSciences spoke about the company’s new facility that features 3,000 sq. ft. of flexible suite space.
The facility, which will be up and running in Q3 this year, is purpose built around several technologies, including nano-milling, homogenization, aseptic processing
“We expect the capacity of this facility to be occupied pretty quickly,” said Mitchnick. He added that the company has already begun “expansion of the expansion” and is looking to establish additional long-term relationship with companies.